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Only recently have we fully appreciated
that the classically separated domains
of neurology, endocrinology, immunol-
ogy and microbiology, with their various
organs- the brain, glands, gut, immune
cells and microbiota, could actually be
joined to each other in a multidirectional
network of communication, in order to
maintain homeostasis. For example, local
and systemic immune activation have
profound neural and behavioral effects
(Campos-Rodríguez et al., 2013), neu-
roendocrine hormones regulate immune
cytokines, and together, the nervous sys-
tem and immune system work together
in synergy to protect the body from
infection (Steinman, 2004). Analogously,
the gut microbes greatly impact the host
immunological, psychological, and over-
all well-being of the host (Collins and
Bercik, 2013; El Aidy and Kleerebezem,
2013a; Wang and Kasper, 2013; Moloney
et al., 2014). However, definitive mecha-
nisms that orchestrate a functionally rele-
vant communication within this network,
in particular, during the early life develop-
ment, are yet to be elucidated. A potential
unifying mechanism very likely involves
multiple-functioning molecules and their
receptors, as they are produced by, act
upon and move from one system to
another linking the brain, gut, immune
system, and microbiota. These messenger
molecules include (among others) neu-
rotransmitters, neuropeptides, endocrine
hormones, and cytokines.
The physiological phenomenon of
maturation of the immune and neuro-
logical systems, as well as the microbial
colonization, initiated within the fetal
period, are dynamic in their character
and are expanding in time through the
first months and even years of human’s
life. The mode of delivery, be it vaginal
birth or caesarean-section, has recently
been shown to be critical in determin-
ing the pioneer microbial composition of
neonates (Dominguez-Bello et al., 2010).
Particularly over the first few years of
life, as the microbiota develops, there
is a greater potential for disruption of
the long-term microbial state upon the
repeated use of antibiotics (Lemon et al.,
2012). Not only does the antibiotics use
disrupt the microbial community in
healthy infants but also it amplifies the
microbial dysbiosis in pediatric patients
with Crohn’s disease (Gevers et al., 2014).
Several reports have shown that dysbio-
sis alone as may result from antibiotic
treatment is sufficient to drive intesti-
nal inflammation (Hooper et al., 2012).
Additionally, alterations of the microbial
composition are often associated with
changes in brain development and plas-
ticity and alterations in motor, anxiety
and social behavior (Sudo et al., 2004;
Diaz-Heijtz et al., 2011; Neufeld et al.,
2011; Clarke et al., 2013; Desbonnet et al.,
2014). Consequently, abrupt shifts dur-
ing the infant’s unique developmental
path through this early unstable phase
may have longer term health implications
(Costello et al., 2012). Activation of the
(innate) immune response during the pri-
mary colonization involves the induction
of toll-like receptors (TLRs) (Carvalho
et al., 2012; El Aidy et al., 2012a, 2013b)
and is linked to the stress induced by colo-
nization, which increases gut permeability
(Dinan and Cryan, 2012) to the colo-
nizing microbes and their metabolites.
Although very crucial in the recogni-
tion of the gut microbes, the scenario
of immune activation via TLRs appear not
to respond promptly at the initial stage
of colonization (El Aidy et al., 2013c),
suggesting that the very rapid actions of
neurotransmitters and hormones might
be important to control the priming
and migration of cells of the first line of
defense. Several members of pioneer gut
colonizers are able to produce neurotrans-
mitters. Escherichia and Streptococcus, for
instance, can produce norepinephrine and
serotonin (5-HT), whereas, Lactobacillus
and Bifidobacterium can produce GABA
and acetylcholine (Roshchina, 2010; Lyte,
2011). Mobile cells of the immune system
express receptors for neurotransmitters
(Pert et al., 1985). For example, migra-
tion of immature dendritic cells (DCs) to
lymph nodes is mediated via α1 adrenergic
receptors (Maestroni, 2000), emphasizing
the early effects of the sympathetic ner-
vous system (SNS) at the start of a local
immune response. Norepinephrine, a neu-
rotransmitter of the SNS (among other
molecules stored in sympathetic vesicles),
has pro-inflammatory effects at low con-
centration mediated through binding to
α2 adrenoceptors and reduction of cAMP
levels (Spengler et al., 1990). On the other
hand, acetylcholine, the principle vagal
neurotransmitter, attenuates the release
of cytokines [tumor necrosis factor-alpha
(TNF- α), interleukin (Il)-1β, Il-6 and
Il-18, but not the anti-inflammatory
cytokine Il-10, in lipopolysaccharides
(LPS) stimulated human macrophage cul-
tures (Borovikova et al., 2000)]. Moreover,
choline acetyltransferase (ChAT), the
key enzyme in the synthesis of acetyl-
choline, is expressed by B cells, DCs, and
macrophages in the mucosal-associated
lymphoid tissue (MALT). Reardon et al.
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reported that ChAT expression begins after
microbial colonization, following birth,
and requires MyD88-dependent signal-
ing derived from the intestinal microbiota
(Reardon et al., 2013). Monocytes such as
macrophages and other leucocytes travel
through the blood and when they come
within scenting distance of a given neuro-
transmitter, they begin to chemotaxically
orient toward it, and then communicate
with other immune cells in the adaptive
arm such as B and T lymphocytes to ensure
well-coordinated immune response.
In parallel, activation of the nervous
system, such as afferent vagus nerve
fibers by cytokines stimulates neuronal
anti-inflammatory responses (Sternberg,
1997). Immune cells can produce vari-
ous neurotransmitters and other factors,
which alert the brain to the changes that
occur in the body and affect the plas-
ticity of the local and central nervous
systems, thereby can regulate mood and
behavior. Leukocytes, for example, syn-
thesize and release corticotropin (ACTH)
and endorphins in response to bacterial
LPS (Harbour-McMenamin et al., 1985).
Mounting an innate immune response
during pathogenesis and transiently, dur-
ing primary gut colonization results in
the production of pro-inflammatory
cytokines such as Il-1β, TNF- α, and
IFN-γ (El Aidy et al., 2013c). The pro-
inflammatory cytokine- Il-1β, for instance,
is able to inhibit the release of nore-
pinephine from noradrenoceptor axon
terminals, in the intestine via the induc-
tion of nitric oxide (Rühl et al., 1994;
Rühl and Collins, 1997). To note, nore-
pinephrine via β adrenergic signaling,
inhibits many aspects of the innate
and Th1 mediated immune response
(Straub et al., 2006), whereas activated
macrophages and other innate immune
cells produce nerve repellent factors
directed toward sympathetic nerve to
counteract the sympathetic inhibitory
effect (Miller et al., 2004). Importantly,
another possible mechanism underlying
the reduced levels of norepinephrine dur-
ing mounting innate and Th1 mediated
immune responses is the decreased L-
DOPA decarboxylase activity-the enzyme
that converts L-DOPA to norepinephrine,
as observed in both inflamed and non-
inflamed colonic mucosa of Crohn’s
patients (Magro et al., 2002).
One mechanism through which
immune activation or immunomodula-
tion may affect physiology and behavior is
via actions on serotonergic systems (Lowry
et al., 2007). Analogous to the action of gut
microbiota during primary colonization,
Lowry et al. found that the non-
pathogenic Mycobacterium vaccae led to
stimulation of the peripheral immune sys-
tem. The Th1 and Treg but not Th2 medi-
ated immune activation stimulated a spe-
cific subset of serotonergic neurons in the
dorsal raphe nucleus of mice and increased
serotonin metabolism within the ventro-
medial prefrontal cortex (Lowry et al.,
2007). This finding demonstrates that the
type of peripheral immune response is
important in determining the effects on
serotonergic neurons. Additionally, the
study of Lowry and co-workers suggests
that the immune-responsive subpopula-
tion of serotonergic neurons in the dorsal
raphe appears to play an important role in
the regulation of mood during the health
state. Afferent fibers within the vagus
nerve could be involved in transferring
signals of peripheral immune activation to
the CNS (Maier et al., 1998). The reg-
ulating mechanism appears to involve
enhancement of c-Fos expression in dor-
sal raphe nucleus serotonergic neurons
(Hollis et al., 2006). It is therefore tempt-
ing to speculate that immune activation
under physiological conditions stimu-
lates a subset of serotonergic neurons,
distinct from those activated under patho-
logical conditions or by uncontrollable
stressors. Nevertheless it is unclear if this
association reflects a causal or reactionary
response. Immune activation induces
symptoms of depression and anxiety in
human patients including disorders such
as irritable bowel syndrome (IBS), a disor-
der of the gut-brain axis (Clarke et al.,
2009) and in patients receiving treat-
ment with interferon (Felger et al., 2013).
Treatment with serotonergic antidepres-
sant drugs prevents the onset of depressive
symptoms in such situations (Capuron
and Miller, 2004; Capuron et al., 2004).
Moreover, recent data has shown that
the TNF antagonist infliximab reduces
depression symptoms in a subset of
patients with high baseline inflammatory
biomarkers (Raison et al., 2013). Of note,
local and systemic depletion of the 5-HT
precursor- Tryptophan (Trp) is associated
with elevation of the immunomod-
ulatory enzyme Indoleamine-pyrrole
2,3-dioxygenase (IDO), which occurs
during immune activation (Moffett and
Namboodiri, 2003) and transiently during
primary gut colonization (El Aidy et al.,
2012b, 2013b). Moreover, 5-HT is altered
by the gut microbiota, being elevated in
conventionally raised mice, only when gut
colonization occurs at birth (Clarke et al.,
2013). Collectively, these findings illus-
trate evidence that serotonergic systems
may play an important role in the rela-
tionship between the immune function,
gut microbiota, and psychological state.
Local and systemic elevation of pro-
inflammatory cytokines, in particular, Il-
1β and Il-6 and altered 5-HT levels
cause activation of the hypothalamic-
pituitary-adrenal (HPA) axis and pro-
duction of corticotrophin releasing fac-
tor (CRF). CRF, which is also elevated
in stress response, causes disturbance to
other neuropeptides, leading to changes in
mood and behavior (Dinan and Cryan,
2012). CRF stimulates the anterior pitu-
itary gland to release the stress hor-
mone; ACTH, which in turn stimulates
release of cortisol from the adrenal gland.
Cortisol, through a feedback loop, reg-
ulates the levels of CRF, and ACTH.
Importantly, immune cells, through the
COX-2 pathway and production of PEG-
2 during (pro-) inflammation, stimulate
the adrenal gland to produce corticos-
terone, which exclusively supports the β
adrenergic pathway through which the
SNS perform its anti-inflammatory effect
(Straub et al., 2006). This indicates that
under normal conditions the neuroen-
docrine and immune systems coordinate
to ensure maintenance of homeostasis.
Indeed, patients with IBS show inade-
quately low concentration of the anti-
inflammatory steroid hormone, cortisol
(Straub et al., 2002).
In conclusion, we assume that the
intimate communication between the
microbiota-immune-neuroendocrine
systems involves multiple-functioning
molecule(s). Those same molecule(s)
appear to be produced by and signal mem-
ber(s) of the gut microbial community, the
neuroendocrine and immune systems to
mount or avoid rising an attack response
against the commensals. This would be
of crucial importance early in life. During
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this vulnerable period, it is believed to exist
a narrow window during which coloniza-
tion with a “healthy” microbiota exerts
effects that may decrease susceptibility to
diseases and ensure normal development
of the mucosal and systemic immunity
and metabolism as well as the develop-
ment of HPA axis,which impacts on the
gut through its action on the enteric ner-
vous system, immune system and the CNS
(Sudo et al., 2004; Shreiner et al., 2008).
The most important question needed to
be answered at this point, what would be
the molecular mechanisms underlying the
intimate cross-talk between the immune
system and the microbiota-gut-brain axis
at its various nodes of interaction?
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